Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Trial of Valproate to Attenuate the Progression of Alzheimer's Disease (AD)
NCT00071721 is registered in ClinicalTrials.gov with Alzheimer's Disease Cooperative Study (ADCS) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Trial of Valproate to Attenuate the Progression of Alzheimer's Disease (AD)
- Lead sponsor
- Alzheimer's Disease Cooperative Study (ADCS)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2003
- Completion date
- December 31, 2009
- Enrollment
- 313 (actual)
- Sites
- 46
Conditions
As the registry lists them; a condition with its own page is linked.